During the COVID pandemic, healthcare systems in Brazil have responded strongly, leading to several new opportunities, including investment and business options. Post-pandemic opportunities include:

Development of cutting-edge vaccines, with increasing participation of local research centers and laboratories;

Progress in digital health regulation;

Expansion of hospital complexes and healthcare infrastructure;

Demand for innovative medical products and for venture capital in healthcare.

These opportunities demonstrate the great potential for continued growth of the Brazilian market. This forum presented an overview of the market and addressed current challenges and business opportunities in the Brazilian life science and healthcare sectors.

Moderators:

Gustavo Kesselring, MD, GFMD, Vice President & External Affairs, IFAPP Academy Inc.

James Rosenstein, International Business Consultant, JSR International Consulting, LLC

Program and Speakers:

Telehealth and Data Protection in Brazil: “Digital health in the post-pandemic world”

Speaker: Rubens Granja, Partner, Head of the Life Sciences & Healthcare Practice, Lefosse

Clinical Research for pharmaceutical industries in Brazil and Latin America: “Expansion, opportunities, lessons learned during the pandemic and decentralized clinical trials”

Speaker: Luis Russo, MD, PhD, MBA, CEO, Care Access Brazil

Healthtech Startups in Brazil: “Opportunities for healthtech in the Brazilian post-pandemic market”

Speaker: Bruno Porto, Partner, Leader of Brazil Health Industries and Services, PwC

Check out our highlights

To watch this event details check out on our YouTube profile.